1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 02 FEBRUARY 2015

CNS Drug News 02 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Branded Antidepressants Market Has High Potential Despite Current Contraction
Industry Brief - AgeneBio Receives Grant For New Approach To Delaying Onset Of Alzheimer's Dementia
Industry Trend Analysis - Supreme Court Ruling Will Boost Teva's Copaxone Revenues
Industry Brief - Reata Enrols First Patient In Study Of RTA 408 For FA
Industry Trend Analysis - J&J's Three-Month Antipsychotic Will Be A Growth Driver
Industry Trend Analysis - Europe Opening Up To Adult ADHD
Industry Brief - Richter/Actavis Report Positive Phase III Results For Cariprazine
Industry Brief - BDSI Acquires North American Marketing Authorisations For Onsolis From Meda
Industry Trend Analysis - Zohydro ER's Abuse-Deterrent Label Delay Will Benefit Purdue
Industry Brief - Purdue's Abuse-Deterrent Hysingla ER Available In US
Industry Brief - Antares' Sumatriptan ANDA Receives CRL
Industry Brief - Premier Files Initial FDA Submission For Fibromyalgia Treatment
Industry Trend Analysis - Mounting Patent Challenges Will Determine Supernus' Financial Rewards
Industry Brief - UCB's Brivaracetam Applications Accepted For Review By FDA/EMA
Industry Brief - Exalief Soon To Be Available In Russia
Industry Brief - Impax Receives US Lamotrigine Approval
Industry Brief - Supernus Files Oxcarbazepine Patent Lawsuit Against TWi
Industry Brief - Alexza Initiates Phase IIa Study Of AZ-002 In Epilepsy Patients
Industry Brief - Vyvanse Becomes First FDA-Approved Treatment For Moderate-To-Severe BED In Adults
Industry Brief - Helsinn Grants Stendhal Exclusive Rights To NEPA In Multiple Countries Of Latin America
Industry Brief - PsychoGenics Achieves Further Milestone In Sunovion Collaboration
Industry Trend Analysis - Further Double-Digit Revenue Growth And Increased EPS For Biogen Idec In 2015
Industry Brief - Otsuka Opens Office In Australia

Table Of Contents

CNS Drug News 02 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.